Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2025
Chronic liver injury decreases levels of cerebral carnitine and acetylcarnitine in rats partly due to the downregulation of organic cation transporters OCT1/2 and OCTN2 at the blood-brain barrierHao Zhi, Zhongyan Wang, Xinyue Zhu, et al.
Plos One|March 17, 2017
Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patientsJianfu Heng, Xinwu Guo, Wenhan Wu, et al.
Redox Biology|January 1, 2024
Bile duct ligation elevates 5-HT levels in cerebral cortex of rats partly due to impairment of brain UGT1A6 expression and activity via ammonia accumulationHanyu Yang, Linjun You, Zhongyan Wang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2006
In vivo expansion of two distinct dendritic cells in mouse livers and its impact on liver immune regulationYalan Wang, Ning Zheng, Zhengbin Lu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 2, 2003
[Assessment of nasopharyngeal carcinoma risk by EB virus antibody profile]Weimin Cheng, Guoxiong Chen, Honglin Chen, et al.
Cancer Management and Research|March 23, 2026
Saikosaponin D Induced Apoptosis and Anti-Tumor Effect Enhancing Chemotherapy Sensitivity of Gemcitabine in Patient-Derived Cholangiocarcinoma OrganoidsBing Han, Guoqiang Xing, Kunkun Du, et al.
Frontiers in Immunology|July 16, 2026
OTU deubiquitinases as immune-circuit editors: from human immunopathology to therapeutic prioritizationYi Guo, Yue Song, Chenxin Wang, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
In vivo immune modulatory activity of hepatic stellate cells in miceCheng-Hsu Chen, Liang-Mou Kuo, Yigang Chang, et al.
Frontiers in Pharmacology|August 6, 2024
Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic targetChunyan Zhang, Jie Zheng, Jin Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 17, 2014
Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver diseaseWen Su, Yang Wang, Xiao Jia, et al.
Pageof 6